Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Clicks: 608
ID: 120397
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #3 of 14 articles by views in the american journal of psychiatry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials. The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.
Reference Key
mh2006theevaluation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Trivedi MH;Rush AJ;Wisniewski SR;Nierenberg AA;Warden D;Ritz L;Norquist G;Howland RH;Lebowitz B;McGrath PJ;Shores-Wilson K;Biggs MM;Balasubramani GK;Fava M; ;;
Journal the american journal of psychiatry
Year 2006
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.